Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$22.41
-0.44-1.93%
At close: Jan 15, 4:00 PM EST
$22.85
N/A
Pre-Market: 4:21 AM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immunome (IMNM) stock?
You can purchase shares of Immunome (NASDAQ:IMNM) through any online brokerage.
Who are Immunome (IMNM) competitors?
Other companies in Immunome’s space includes: Twist Bioscience Corp (NASDAQ:TWST), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Sarepta Therapeutics Inc (NASDAQ:SRPT), Ascentage Pharma Group International (NASDAQ:AAPG) and Mesoblast Ltd (NASDAQ:MESO).
What is the forecast, or price target, for Immunome (IMNM) stock?
Immunome has a consensus price target of $26.00.
What is the current price for Immunome (IMNM)?
The stock price for Immunome (NASDAQ: IMNM) is $22.85 last updated January 16, 2026 at 6:50 PM EST.
Does Immunome (IMNM) pay a dividend?
There are no upcoming dividends for Immunome.
When is Immunome (NASDAQ:IMNM) reporting earnings?
Immunome does not have any upcoming earnings scheduled.
Is Immunome (IMNM) going to split?
There is no upcoming split for Immunome.
What sector and industry does Immunome (IMNM) operate in?
Immunome is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
